Carbidopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Carbidopa.
| Product ID | 43975-220_093c7ccd-9e02-42ac-84a6-9e62923e42a4 |
| NDC | 43975-220 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carbidopa |
| Generic Name | Carbidopa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-03-10 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203261 |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Substance Name | CARBIDOPA |
| Active Ingredient Strength | 25 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-03-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA203261 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-03-10 |
| Ingredient | Strength |
|---|---|
| CARBIDOPA | 25 mg/1 |
| SPL SET ID: | c47856c9-7013-44a2-b381-4ca67e1d1b4c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16714-067 | Carbidopa | Carbidopa |
| 40032-980 | Carbidopa | Carbidopa |
| 42799-123 | Carbidopa | Carbidopa |
| 43386-980 | Carbidopa | Carbidopa |
| 43975-220 | Carbidopa | Carbidopa |
| 51407-314 | Carbidopa | Carbidopa |
| 59651-146 | Carbidopa | Carbidopa |
| 63629-1932 | Carbidopa | Carbidopa |
| 63629-9193 | Carbidopa | Carbidopa |
| 68682-200 | Carbidopa | Carbidopa Tablets |
| 70710-1221 | CARBIDOPA | CARBIDOPA |
| 70771-1355 | CARBIDOPA | CARBIDOPA |
| 25010-711 | Lodosyn | carbidopa |